Kelly T Carter

6PUBLICATIONS
38CO-AUTHORS
Predictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 09, 2023
Elevated EVL Methylation Level in the Normal Colon Mucosa Is a Potential Risk Biomarker for Developing Recurrent Adenomas.

Ming Yu, Kelly T Carter, Kelsey K Baker

|Jun 15, 2022
Novel DNA Methylation Biomarker Panel for Detection of Esophageal Adenocarcinoma and High-Grade Dysplasia.

Ming Yu, Helen R Moinova, Amber Willbanks

|Apr 15, 2022
Colorectal Cancer Is Associated with the Presence of Cancer Driver Mutations in Normal Colon.

Julia Matas, Brendan Kohrn, Jeanne Fredrickson

|Apr 12, 2022
Evaluation of methylated DCR1 as a biomarker for response to adjuvant irinotecan-based therapy in stage III colon cancer: cancer and leukaemia Group B 89803 (Alliance).

Lynn Symonds, Ming Yu, YuHong Zhang

|Aug 08, 2019
Senescence-associated tissue microenvironment promotes colon cancer formation through the secretory factor GDF15.

Yuna Guo, Jessica L Ayers, Kelly T Carter

|Oct 07, 2018
Implications of Epigenetic Drift in Colorectal Neoplasia.

Georg E Luebeck, William D Hazelton, Kit Curtius

Pageof 1

Frequent Collaborators

5 joint publications

William M Grady

4 joint publications

Ming Yu

2 joint publications

John M Inadomi

2 joint publications

Ting Wang